We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

United and Debiopharm Announce the Launch of Pamorelin®

News   Dec 08, 2015

 
United and Debiopharm Announce the Launch of Pamorelin®
 
 
Advertisement
 

RELATED ARTICLES

Light-activated Nanoparticles Inhibit Tumor Growth

News

A unique nanoparticle to deliver a localized cancer treatment inhibits tumor growth in mice, according to new research conducted at Penn State University.

READ MORE

Regulatory T Cells Modified by Key Gene To Fine-tune the Immune Response

News

Researchers have discovered genetic “dial” to control regulatory T cells, a finding that could have implications for cancer and autoimmune disease treatment.

READ MORE

PRC1 Plays a Role in Genetic Errors and Cancer

News

An over-abundance of the protein PRC1, which is essential to cell division, is a telltale sign in many cancer types. Researchers now show that PRC1 acts as a “glue” during cell division, precisely controlling the speed at which two sets of DNA are separated as a cell divides.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE